Phase I/II Study Shows Promise for Melflufen in Multiple Myeloma
Researchers indicated that these results show the feasibility of this regimen and support the development of additional studies of melflufen in multiple myeloma, both in combination with dexamethasone as well as in triplet regimens.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Hannah Slater Source Type: news